1. Introduction {#sec1-marinedrugs-17-00116}
===============

Compared with pacific abalone (*Haliotis discus*), which is a highly valued marine shellfish, the false abalone (*Volutharpa ampullacea perryi*), another deep-sea snail gastropod, is much cheaper but of similar appearance and nutrition value to that of *Haliotis discus* \[[@B1-marinedrugs-17-00116]\]. False abalone is abundantly found in the North Pacific, especially some coasts of China and Japan, where it is consumed as food \[[@B2-marinedrugs-17-00116]\]. Its edible parts contain approximately 50% protein (dry weight) \[[@B3-marinedrugs-17-00116]\], which makes it a potential resource for developing bioactive peptides to increase its commercial value. Marine-derived peptides have been well studied to be used as bioactive components in functional foods or nutraceuticals and pharmaceuticals. However, bioactive peptides produced from false abalone are rarely reported.

Enzymatic hydrolysis for producing peptides basically includes hydrolysis at optimal conditions, termination of hydrolysis, filtration, fractionation or purification, and freeze-drying \[[@B4-marinedrugs-17-00116]\]. Proteolytic enzymes, either endogenous or exogenous, are a group of enzymes that cleave peptide bonds in protein matrices to generate peptide mixtures with different sizes, amino acid compositions and sequences, as well as peptide structures \[[@B5-marinedrugs-17-00116]\]. However, since each proteolytic enzyme has a different degree of specificity, the selection of proteolytic enzymes certainly determines the bioactivity of the produced peptides.

Antioxidative peptides have broad health benefits by controlling oxidative stress, which plays a role as a promoter for some chronic diseases, such as diabetes, atherosclerosis, arthritis, and cancer \[[@B6-marinedrugs-17-00116]\]. The antioxidant effect of peptides can result from the scavenging of reactive oxygen species (ROS) and chelating transition metal ions \[[@B7-marinedrugs-17-00116]\]. Although the exact mechanism of the antioxidant activity of peptides has not been clearly understood, various research studies have found that certain composed amino acids and their locations, as well as the configuration of the peptide, are involved in the interaction with radicals. Such interactions can be evaluated using in silico molecular docking of peptides with myeloperoxidase (MPO). MPO is abundantly expressed in neutrophils and participates in innate immune defense by forming reactive oxidants contributing to tissue damage; therefore, MPO is used in drug design and development for high-throughput screening of compounds based on the enzyme inhibition mechanism \[[@B8-marinedrugs-17-00116]\]. For example, Guerra-Vargas et al. used MPO (Protein Data Bank (PDB) ID: 1DNU) as a target to further study the synthesized new phenolic compounds that serve as antioxidants \[[@B9-marinedrugs-17-00116]\]. Van der Does et al. used human MPO (PDB ID: 3F9P) to study the inhibition effect of a novel antimicrobial peptide on MPO activity \[[@B10-marinedrugs-17-00116]\].

The objectives of the present research are: (i) to optimize the production of antioxidative peptides from false abalone using proteolytic hydrolysis; (ii) to characterize their antioxidant activity of peptide fractions by spectroscopic evaluations of the scavenging of ABTS^+•^ (the diammonium salt of 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)); (iii) to identify the amino acid sequences of the optimized peptides using LC-MS/MS; and (iv) to understand the mechanism via the molecular docking model using MPO.

2. Results and Discussion {#sec2-marinedrugs-17-00116}
=========================

2.1. The Selection of Proteolytic Enzymes {#sec2dot1-marinedrugs-17-00116}
-----------------------------------------

Proteolytic enzymes break down peptide bonds to produce protein hydrolysates, which consist of peptides and amino acids. The commercially used proteolytic enzymes are usually protease cocktails, such as the alcalase, neutrase, and flavourzyme that have low specificity on the amino acids residues; besides, trypsin (EC 3.4.21.4), and pepsin (EC 3.4.23.1) are also widely used and they are highly specific to basic and aromatic amino acids residues, respectively \[[@B11-marinedrugs-17-00116]\]. As mentioned previously, the specificity of enzymes determines the size and the sequence of the peptides, and their antioxidant activity. [Figure 1](#marinedrugs-17-00116-f001){ref-type="fig"}a shows the effect of five proteolytic enzymes on the hydrolysis degree of false abalone hydrolysates. Trypsin produced hydrolysates with the highest hydrolysis degree (12.38 ± 0.62%) (*p* \< 0.01), followed by non-specific neutrase (9.08 ± 0.50%), and alcalase (8.57 ± 0.13%). Hydrolysates produced from flavourzyme, which is usually used to produce hydrolysates as flavor compounds, had the lowest hydrolysis degree (2.63 ± 0.70%), which had no significant difference with the pepsin-produced hydrolysates (hydrolysis degree of 3.55 ± 0.05%) (*p* \> 0.01). Hou et al. reported that trypsin produced Alaska pollock protein hydrolysates with the highest hydrolysis degree compared with nine other proteases due to the substrate specificity on lysine and arginine residues of the trypsin, and that trypsin is usually served in higher activity and purity than other proteases as one kind of serine protease \[[@B12-marinedrugs-17-00116]\]. The effect of the five proteolytic enzymes on the ABTS^+•^ free radical scavenging activity is shown in [Figure 1](#marinedrugs-17-00116-f001){ref-type="fig"}b. Trypsin-produced hydrolysates had the highest ABTS^+•^ scavenging activity of 77.32 ± 1.25% (*p* \< 0.01), with the amount of proteins of 1.0 mg/mL, and its IC50 value calculated to be 0.69 mg/mL. Similarly, Mao et al. found that casein hydrolysates prepared with alcalase and trypsin had significantly higher DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical scavenging capacity than those prepared with pepsin and flavourzyme \[[@B13-marinedrugs-17-00116]\].

The hydrolysis degree and ABTS^+•^ scavenging activity of produced hydrolysates followed similar trends, which suggest that the increase of hydrolysis degree may increase the antioxidant properties of hydrolysates to some extent. Higher hydrolysis could result in a larger exposure of the active amino acids residues that are capable of reacting with oxidants \[[@B14-marinedrugs-17-00116]\]. However, extensive hydrolysis could have a negative impact on the functional properties of hydrolysates \[[@B15-marinedrugs-17-00116]\]. Based on the results shown in [Figure 1](#marinedrugs-17-00116-f001){ref-type="fig"}, trypsin was selected to produce oxidative hydrolysates for subsequent optimization studies.

2.2. Optimum Hydrolysis Conditions {#sec2dot2-marinedrugs-17-00116}
----------------------------------

The hydrolysis degree (Response 1) and ABTS^+•^ free radical scavenging activity (Response 2) are two important indexes of antioxidative hydrolysates produced from enzymes. These two responses obtained under various conditions designed by face-centered central composite design (F-CCCD) are shown in [Table 1](#marinedrugs-17-00116-t001){ref-type="table"}. It indicated that hydrolysis conditions such as temperature, time, and pH could influence the hydrolysis and the bioactive property of hydrolysates produced with trypsin.

Response surface analysis data for the hydrolysis degree of hydrolysates ([Table 2](#marinedrugs-17-00116-t002){ref-type="table"}; Response 1 section) indicated a significant model (*p* \< 0.0001), as well as significant (*p* \< 0.05) linear effects A, B, C; interaction term AB; and quadratic effects A^2^, B^2^, C^2^ for the fitted model, as seen in Equation (1):

The lack of fit was not significant (*p* = 0.1000), indicating that the model fitted the data very well. The maximum predicted hydrolysis degree of 13.34% was obtained according to Equation (1) under the following conditions: temperature 50.82 °C, time 4.04 h, and pH 7.65. As shown in [Figure 2](#marinedrugs-17-00116-f002){ref-type="fig"}a, hydrolysis temperature (A) and time (B) interacted strongly (*p* = 0.0027) with respect to the hydrolysis degree. The highest hydrolysis degree was observed at hydrolysis temperature of 50 °C for 4 h. Higher temperature combined with longer hydrolysis time negatively influenced the hydrolysis degree. The reason could be the inactivation effect on trypsin with temperatures above 50 °C, as long treatment time at high temperatures would reduce the availability of the enzyme, increase the concentration of produced peptides that may inhibit the hydrolysis reaction, and decrease the concentration of peptide bonds that limit the reaction speed. Similar observations have been reported for the yellowfin tuna hydrolysates produced using alcalase \[[@B16-marinedrugs-17-00116]\] and β-lactoglobulin hydrolysates produced using trypsin \[[@B17-marinedrugs-17-00116]\].

ABTS^+•^ scavenging activity is of prime importance for antioxidative hydrolysates because it is used as a parameter to evaluate the antioxidant properties. As shown in [Table 2](#marinedrugs-17-00116-t002){ref-type="table"} (Response 2 section), the corresponding *p* \< 0.0001 indicated the model fitted well with the experimental data, as expressed in Equation (2):

The *p* values for all the effects, i.e., linear effects A, B; interaction terms AB, AC, BC; as well as quadratic effects A^2^, B^2^, C^2^ were significant (*p* \< 0.05). The lack of fit was not significant (*p* = 0.0673), which confirmed an excellent fitting. The optimum predicted ABTS^+•^ scavenging activity of 79.62% was obtained, according to Equation (2), under the following conditions: temperature 52.5 °C, time 4.26 h, and pH 7.75. [Figure 2](#marinedrugs-17-00116-f002){ref-type="fig"}b shows the significant interaction between hydrolysis temperature (A) and time (B) (*p* = 0.0270). At lower temperatures, the ABTS^+•^ scavenging activity increased very slowly when hydrolysis time increased. At higher temperatures (\>50 °C), as shown in the red surface on the top of the three-dimensional (3D) diagram, the ABTS^+•^ scavenging activity of hydrolysates increased significantly with the increase of hydrolysis time from 3.5 to 4.5 h. As seen in [Figure 2](#marinedrugs-17-00116-f002){ref-type="fig"}c, the ABTS^+•^ scavenging activity increased when hydrolysis pH increased. A higher pH combined with moderate hydrolysis temperatures favored the production of hydrolysates with high ABTS^+•^ scavenging activity. [Figure 2](#marinedrugs-17-00116-f002){ref-type="fig"}d shows that at higher pH values (pH 7--8), the ABTS^+•^ scavenging activity increased significantly with the increase of hydrolysis time. The hydrolysis pH had more influence than hydrolysis temperature and time. This might be due to the trypsin used being sensitive to the pH and active at basic pH conditions. A previous study found that hydrolysis time, temperature, and enzyme/substrate ratio had interaction effects on the ABTS^+•^ scavenging activity of fish gelatin hydrolysates prepared using papain \[[@B18-marinedrugs-17-00116]\].

Then, with respect to both hydrolysis degree and antioxidative activity, the first partial derivatives of the regression models were applied to optimize the enzymatic hydrolysis by combining the Equations (1) and (2). Hence, the optimum conditions of hydrolysis temperature at 51.81 °C for 4.13 h at pH 7.7 were determined to produce antioxidative hydrolysates using trypsin, and the maximum predicted hydrolysis degree was 13.27% with ABTS^+•^ scavenging activity of 79.54%. To verify the model, the practical conditions of hydrolysis temperature at 51.8 °C for 4.1 h at pH 7.7 were applied because of the control accuracy of the equipment. New hydrolysates produced under these conditions showed a hydrolysis degree of 13.18 ± 0.31% and ABTS^+•^ scavenging activity of 79.42 ± 0.33%, which showed no significant difference from the predicted data (*p* \> 0.05). The optimized hydrolysates were subjected to fractionation using ultrafiltration to determine the effect of fraction MW on their anti-oxidant properties.

2.3. The Effect of MW {#sec2dot3-marinedrugs-17-00116}
---------------------

The molecular weight of protein hydrolysates that resulted from the enzymatic hydrolysis degree was highly related with their bioactivity. After the ultrafiltration, all the protein hydrolysates were diluted. Then the protein concentration of any fraction was adjusted to 0.1 mg/mL prior to the determination of antioxidant properties. As seen in [Figure 3](#marinedrugs-17-00116-f003){ref-type="fig"}, the ABTS^+•^ scavenging activity of hydrolysate fractions increased significantly from MW of \<10 kDa to MW of 5--10 kDa (*p* \< 0.01), and the increase of activity between hydrolysate fraction 3--5 kDa and \<3 kDa was gradual. The hydrolysate fraction with a MW \< 3 kDa was found to have the highest ABTS^+•^ scavenging activity of 55.37 ± 1.33% (*p* \< 0.01) at a low protein concentration of 0.1 mg/mL. Since the IC50 value of the \<3 kDa hydrolysate fraction was calculated to be 0.09 mg/mL, which was about 7.7 times higher than that of the initial tryptic hydrolysate, the results indicated that the lower the MW of the hydrolysates, the higher the ABTS^+•^ scavenging activity. Protein hydrolysates from fish, beans, milk, etc., with a MW range of 0--3 kDa, have been reported with higher antioxidant properties \[[@B19-marinedrugs-17-00116],[@B20-marinedrugs-17-00116],[@B21-marinedrugs-17-00116]\]. Besides, peptides with lower MW are easier to cross the intestinal barrier and exert the antioxidant effect and can interact more effectively with free radicals \[[@B22-marinedrugs-17-00116]\], which favor their usage as pharmaceuticals.

2.4. Identification of Peptide Sequences by LC--MS/MS {#sec2dot4-marinedrugs-17-00116}
-----------------------------------------------------

The fraction with MW of \< 3 kDa was loaded onto LC--MS/MS to characterize their sequences of the composed amino acids. There were 193 peptides recognized in the hydrolysate fraction, as listed in [Supplementary Table S1](#app1-marinedrugs-17-00116){ref-type="app"}. Results showed that all peptide sequences were made of 6--26 amino acids residues. Previous research has found that bioactive peptides usually contain 2--20 amino acid residues \[[@B23-marinedrugs-17-00116],[@B24-marinedrugs-17-00116]\]. In the current study, the molecular mass of the peptide sequences ranged from 699 to 2560 Da, which also confirmed the effective fractionation using ultrafiltration to produce peptides with MW \< 3 kDa.

The peptide sequences in the MW \< 3 kDa had various amino acid residues at their N- or C-terminals. Trypsin could specifically cleave the C-terminal to arginine (R) or lysine (K) residues. There were 81 peptide sequences (42% of the total peptide sequences) with R or K residues on the C-terminal, which implied the efficiency of enzymatic hydrolysis using trypsin. It has been reported that trypsin-generated peptides from royal jelly protein hydrolysates had high antioxidant and antimicrobial activities \[[@B25-marinedrugs-17-00116],[@B26-marinedrugs-17-00116]\]. The presence of peptide sequences with other residues on the C-terminal may have been caused by the impurity of trypsin enzymes, or autohydrolysis may have occurred with the endogenous digestive enzymes from false abalone, or the breakdown of random peptide bonds at heating treatment (i.e., 51.8 °C for 4.1 h), or the matching degree of the MS/MS database. The diversity of the remaining residues on the peptide sequence terminals contributed to the antioxidant properties. For instance, proline (P) residues at both terminals were found in peptides that had both antioxidant and α-amylase inhibitory activities \[[@B24-marinedrugs-17-00116]\]; the presence of the N-terminal histidine (H) was shown to exert antioxidant protection \[[@B27-marinedrugs-17-00116]\].

Previous research studies have found that antioxidative peptides usually contain hydrophobic amino acids, such as glycine (G), alanine (A), valine (V), leucine (L), isoleucine (I), proline (P), phenylalanine (F), methionine (M), and tryptophan (W) \[[@B28-marinedrugs-17-00116]\]. Those residues were found in almost all the 193 characterized peptide sequences, suggesting that they could enhance the presence of peptides in the water--lipid interaction phase to facilitate the scavenging of free radicals according to the previous study \[[@B29-marinedrugs-17-00116]\]. Among these hydrophobic amino acids, leucine (L) was found in the majority of the characterized peptides. This was in agreement with research on peptides from buffalo and bovine casein hydrolysates with high antioxidant properties \[[@B30-marinedrugs-17-00116]\]. It might be due to the long aliphatic side chain from leucine residues that contributed to the interaction with the acyl chains of fatty acids \[[@B31-marinedrugs-17-00116]\]. Besides, amino acid residues, such as histidine (H), and cysteine (C) are also found in the peptides sequences, which have been reported with relation to radical scavenging activity due to their special characteristics, such as the imidazole group in histidine and the sulfur hydrogen donated by cysteine \[[@B32-marinedrugs-17-00116]\].

2.5. Molecular Mechanism {#sec2dot5-marinedrugs-17-00116}
------------------------

There were 133 among 193 identified peptide sequences successfully being docked with the MPO enzyme, which suggested that 69% of peptides in the false abalone hydrolysate with MW \< 3 kDa had potential antioxidant activity in vivo. These 133 peptide sequences had a total of 820 docking poses (data not shown), and based on the "score ligand poses" function with calculations from LigScore1, LigScore2, PLP1, PLP2, Jain, PMF, PMF04, and CDOCKER scores algorithms, 107 best poses from 107 peptides were returned and listed in [Table 3](#marinedrugs-17-00116-t003){ref-type="table"}, which were ordered by the consensus scores based on the scores that had been previously computed. Peptide no. 39 with 8 amino acid residues Asp--Thr--Glu--Thr--Gly--Val--Pro--Thr (DTETGVPT) had the best consensus score. There were another 39 peptide sequences in number had consensus scores of 2, and the amounts of peptides with consensus scores of 1 and 0 were 53 and 14, respectively. The reference bioactive peptide hLF1-11, made up of 11 amino acid residues (Gly--Arg--Arg--Arg--Arg--Ser--Val--Gln--Trp--Cys--Ala, GRRRRSVQWCA), has been characterized in structure \[[@B10-marinedrugs-17-00116],[@B33-marinedrugs-17-00116]\]. The docking study of this hLF1-11 with MPO showed that several electrostatic interactions were involved so that hLF1-11 could occupy the active site of MPO and block its catalytic activity \[[@B10-marinedrugs-17-00116]\]. In this study, we used hLF1-11 to compare with the docked peptides, especially peptide no. 39, using the docking procedure described in [Section 3.9](#sec3dot9-marinedrugs-17-00116){ref-type="sec"}, to help to illustrate the molecular mechanism of peptide no. 39 for its antioxidant effect.

Reference peptide hLF1-11 and peptide no. 39 had similar interaction energy around a value of −120. As shown in [Table 3](#marinedrugs-17-00116-t003){ref-type="table"}, the interaction sites between peptide no. 39 and amino acids residues of MPO were similar to those between the reference peptide and MPO. For the LF1-11, the interactions with MPO were amino acids ARG 31 on the A chain, VAL30, ARG31, and TRP32 on the B chain, ARG323 and LYS505 on the C chain, and ALA152, CYS153, ILE160, and LYS505 on the D chain. Nevertheless, peptide no. 39 seemed to have a stronger binding with MPO than LF1-11, as not only the mentioned amino acids above, but also the TRP32 on the A chain of MPO, ALA28, PHE29 on the B chain, ILE160 on the C chain, and THR159 and ARG323 on the D chain were also involved in the peptide no. 39 and MPO interactions. The binding of peptide no. 39 onto these amino acid residues may have interrupted the rigid hydrogen bond, electrostatic interaction, and covalent bond network in the active site that are important for catalysis by MPO \[[@B34-marinedrugs-17-00116],[@B35-marinedrugs-17-00116]\].

As shown in [Figure 4](#marinedrugs-17-00116-f004){ref-type="fig"}, there is structure similarity observed between reference hLF1-11 and peptide no. 39. Peptide no. 39 physically suited well in the docking pocket of MPO with the similar length. It could be observed from the docking model in [Figure 4](#marinedrugs-17-00116-f004){ref-type="fig"} that peptide no. 39 was able to block the active sites of MPO to inhibit the catalytic activity of MPO. From the structure comparison of hLF1-11 and peptide no. 39, the interactions involved were similar. The charge interactions were found between peptides (hLF1-11 and peptide no. 39) and MPO residues ARG323 and LYS505, for example, via the --COO group of peptide no. 39 and --NH group of arginine residue in MPO. Peptide no. 39 also formed hydrogen bonds from the −C=O and --NH groups of peptides to the ARG31 and ILE160 residues in MPO, and these two residues were also involved in hydrogen bond formation between reference hLF1-11 and MPO pocket. C--H bonds were predicted to be formed between peptide no. 39 and amino acid residues VAL30, TRP32, and THR159, which were also associated in the C--H bond interactions between reference and MPO. The difference in the predicted interactions was that 1 pi sulfur interaction was predicted between reference hLF1-11 and PHE439 in MPO, as well as 3 acyl interactions predicted between peptide no. 39 and ALA152, CYS153, and ALA28 in MPO. The molecular docking ([Figure 4](#marinedrugs-17-00116-f004){ref-type="fig"}) indicated that peptide no. 39 (DTETGVPT) was similar in structure as well as the interactions with amino acid residues in the MPO active site, which made it possible for peptide no. 39 to perform antioxidative activity in vivo.

3. Materials and Methods {#sec3-marinedrugs-17-00116}
========================

3.1. Materials and Reagents {#sec3dot1-marinedrugs-17-00116}
---------------------------

Fresh false abalone were purchased from the local market in Dalian, China. The water content and protein content of the false abalone samples were 77.53 ± 2.13% and 18.24 ± 1.03% using methods GB/T5009.3-2016 and GB/T5009.5-2016, respectively. Five proteases including pepsin (≥400 units/mg protein), alcalase (≥200 units/mg protein), trypsin (≥2500 USP units/mg protein), neutrase (≥600 units/mg protein), and flavourzyme (≥300 units/mg protein) were purchased from Sinopharm Chemical Reagent Co., Ltd., Shanghai, China. Other chemicals and reagents were of analytical degree.

3.2. Proteolytic Hydrolysis of False Abalone {#sec3dot2-marinedrugs-17-00116}
--------------------------------------------

False abalone samples were blended in different buffer solutions (pH 2.0, 7.0, 8.0, and 10.0) at the ratio of 3% (w/v). Five proteases were added at a concentration of 7% (w/v) individually. The commercial recommended hydrolysis temperatures and pH values for each protease were applied as: pepsin at 37 °C, pH 2.0; alcalase at 50 °C, pH 10.0; trypsin at 50 °C, pH 8.0; neutrase at 50 °C, pH 7.0; and flavourzyme at 55 °C, pH 7.0. After 3 h hydrolysis, the mixtures were treated at 100 °C for 10 min to inactivate the proteases, followed by centrifugation at 8000 rpm for 15 min. The supernatants were collected as false abalone hydrolysates.

3.3. Determination of Protein Concentration and Hydrolysis Degree {#sec3dot3-marinedrugs-17-00116}
-----------------------------------------------------------------

The protein concentration of hydrolysate was measured using the BCA Protein Assay Reagent Kit (Beyotime Biotechnology Co., Shanghai, China) following the instructions. The hydrolysis degree of hydrolysate was determined based on the content of amino nitrogen using the formol-titration method according to GB/T5009.39-2003. Briefly, 1 mL hydrolysate sample was diluted with 60 mL distilled water and was then titrated to pH 8.2 using 0.05 M NaOH solution (V~a~). Formaldehyde solution of 10 mL was added, and the mixture was titrated continuously to pH 9.2 using a 0.05 M NaOH solution (V~b~). The NaOH solution consumed after formaldehyde addition was V~sample~ (i.e., V~b~ -- V~a~). Blank was performed using distilled water instead of hydrolysates, and the NaOH solution consumed after formaldehyde addition was V~blank~. The hydrolysis degree was calculated using Equations (3) and (4) with samples before and after hydrolysis. Total amino nitrogen was measured using samples after complete hydrolysis with acid treatment for 12 h. where c is the concentration of NaOH solution used, and 0.014 is the nitrogen content equivalent to 1 mL 1 M NaOH solution.

3.4. Antioxidant Activity Determination of Hydrolysates Using ABTS^+•^ Assay {#sec3dot4-marinedrugs-17-00116}
----------------------------------------------------------------------------

The ABTS^+•^ free radical scavenging activity was determined using the method as described by Li et al. \[[@B36-marinedrugs-17-00116]\] with slight modification. Briefly, ABTS^+•^ free radical was generated in darkness using 10 mL of 7 mM ABTS and 176 µL of 130 mM potassium persulfate for 16 h. The ABTS^+•^ solution was diluted with 60% ethanol to an absorbance of 0.70 ± 0.02 at 733 nm. A hydrolysate sample of 1 mL was mixed with 3.9 mL ABTS^+•^ solution, and the absorbance was measured after 10 min at 733 nm (A~sample~). Blank was measured using ethanol instead of the hydrolysate sample, and the absorbance measured as A~blank~. ABTS^+•^ free radical scavenging activity was calculated using Equation (5):

3.5. Selection of Proteolytic Enzyme {#sec3dot5-marinedrugs-17-00116}
------------------------------------

The false abalone hydrolysates produced using five different proteolytic enzymes were subjected to 3.3 and 3.4 to select the best enzyme that produced the highest hydrolysis degree and ABTS^+•^ free radical scavenging activity, which was further used in 3.6 for the optimization of the optimal hydrolysis conditions.

3.6. Response Surface Methodology {#sec3dot6-marinedrugs-17-00116}
---------------------------------

A three-factor face-centered central composite design (F-CCCD) was applied with hydrolysis temperature (°C), hydrolysis time (h), and hydrolysis pH as independent variables, and hydrolysis degree (%) and ABTS^+•^ free radical scavenging activity (%) as responses. The three uncoded levels corresponding to the codes (−1, 0, +1) of the three independent variables were chosen based on preliminary testing. Using the 17 experimental combinations, the following second-degree polynomial model was fitted (Equation 6): where Y is the estimated response; A, B, C are independent variables, i.e., hydrolysis temperature, hydrolysis time, and hydrolysis pH, respectively; β~0~ is the intercept coefficient; β~1~, β~2~, and β~3~ are the linear coefficients; β~11~, β~22~, and β~33~ are the quadratic coefficients; and β~12~, β~13~, β~23~ are the linear by linear interaction coefficients. The model includes linear, quadratic, and interaction coefficients.

3.7. Fractionation of the Optimized Hydrolysates {#sec3dot7-marinedrugs-17-00116}
------------------------------------------------

The optimized hydrolysates produced at the optimal conditions were fractionated using a polyethersulphone (PES) ultrafiltration membrane (Millipore Co., USA) with a MWCO of 10, 5, and 3 kDa. Four fractions were obtained with a MW of \< 3, 3--5, 5--10, and \>10 kDa. These fractions were analyzed for ABTS^+•^ free radical scavenging activity, and the fraction with the highest activity was subjected to 3.8.

3.8. LC--MS/MS Assay {#sec3dot8-marinedrugs-17-00116}
--------------------

The peptide sequences in the hydrolysate fraction were identified using LC--MS/MS. The LC system was equipped with an RP-C18 column (125 mm × 3 mm, particle size 5 μm, Guangzhou FLM Scientific Instrument Co., Ltd., Guangzhou, China), and was operated with mobile phases: solvent A (0.1% (v/v) formic acid in water) and solvent B (acetonitrile supplemented with 0.1% (v/v) formic acid). The column was equilibrated with 95% solvent A. Samples were loaded from the autosampler into the column and then separated with gradient conditions (B%): 0--30 min 4--50%, 30--34 min 50--100%, and 34--35 min 100%. The MS/MS analysis was performed in quadruple using an Orbitrap mass spectrometer (Q Exactive mass spectrometer, Thermo Fisher Scientific Co., Bremen, Germany). Full scan spectra were acquired over m/z 350--2000 and 10 MS2 scans were selected. The software packages of Mascot 2.2 and Uniprot database were used to process and analyze the data.

3.9. Molecular Docking {#sec3dot9-marinedrugs-17-00116}
----------------------

The molecular docking studies were based on the crystal structure of the human MPO (PDB ID: 3F9P) at a resolution of 2.93 Å \[[@B37-marinedrugs-17-00116]\]. The molecular mechanism of peptide interaction with MPO was performed using advanced molecular docking software, Discovery Studio 2017R2 (Accelrys, San Diego, CA, USA) by the CDOCKER model. During the algorithm, the receptor is set as rigid while the peptides (ligands) can be flexible. The "Receptor--Ligand Interactions" performance parameters were set as: (i) Top hits---10, Pose cluster radius---0.5; (ii) Random conformations---10, Dynamics steps---1000, Dynamics target temperature---1000, Include electrostatic interactions---True; (iii) Orientations to refine---10, Maximum bad orientations---800, Orientation vdW energy threshold---300; (iv) Simulated annealing---True, Heating steps---2000, Heating target temperature---700, Cooling steps---5000, Cooling target temperature---300; (v) Forcefield---CHARMm (Chemistry at HARvard Macromolecular Mechanics), Use full potential---False, Ligand partial charge method---Momany--Rone, Final minimization---full potential, Final minimization gradient tolerance---0, Final minimization gradient tolerance---0, Prepare input receptor---True, Grid extension---8.0, Random number seed---314159; (vi) Parallel processing---True, Batch size---1.

Before docking, the MPO structure was treated with the Prepare Protein program in Discovery Studio to build loops, minimize the energy, and protonize and remove water molecules. As shown in [Figure 5](#marinedrugs-17-00116-f005){ref-type="fig"}, the docking pocket was defined based on the active sites of MPO described previously, and the human lactoferrin-derived peptide hLF1-11 was used as the reference peptide \[[@B10-marinedrugs-17-00116]\]. Prior to the docking, the identified 193 peptides were minimized in energy using the following parameters: (i) Algorithm---Smart minimizer, Max steps---200, RMS gradient---0.1, Energy change---0, Save results frequency---0; (ii) Nonbond list radius---14, Nonbond higher cutoff distance---12, Nonbond lower cutoff distance---10; (iii) Electrostatics---Automatic.

3.10. Statistical Analysis {#sec3dot10-marinedrugs-17-00116}
--------------------------

Design Expert version 8.0 (Stat-Ease Inc., Minneapolis, MN, USA) was used to perform surface response analysis, including the ANOVA decomposition and significance tests for model coefficients, the optimization of the response as a function of the independent variables, and the plotting of the fitted surface. Triplicates were performed, and the results were given as mean ± SD. The significance was analyzed using SPSS 11.5 (SPSS Inc, Chicago, IL, USA) with a significance level of *p* \< 0.01.

4. Conclusions {#sec4-marinedrugs-17-00116}
==============

The false abalone hydrolysates produced from proteolytic enzymes have antioxidant properties. Trypsin was found to produce hydrolysates with the highest hydrolysis degree and the highest ABTS^+•^ free radical scavenging activity than other proteases such as pepsin, alcalase, neutrase, and flavourzyme. The optimization of the use of trypsin to produce hydrolysates was of practical importance. Hydrolysate fractions with lower MW showed higher ABTS^+•^ free radical scavenging activity, and 193 peptide sequences were characterized using the LC-MS/MS. There were 133 peptides successfully docked onto the MPO enzyme and 107 of them were characterized with interactions. Peptide no. 39, with amino acid sequence of DTETGVPT, showed the highest consensus score, and its structure as well as the molecular interactions with the amino acid residues in active sites of MPO were similar to a previously characterized peptide hLF1-11. The predicted interactions between peptide no. 39 and MPO included charge interactions, hydrogen bonds, and covalent bonds, which suggested peptide no. 39 might be a potential inhibitor for MPO. Thus, our findings suggested the peptides in the produced antioxidative hydrolysate may exert antioxidant activity *in vivo*, which have application potential in the development of pharmaceuticals and functional foods.
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![The effect of proteolytic enzymes on the (**a**) hydrolysis degree and (**b**) ABTS^+•^ free radical scavenging activity of hydrolysates (the amounts of proteins: 1.0 mg/mL). Different letters in one panel mean significant difference (*p* \< 0.01).](marinedrugs-17-00116-g001){#marinedrugs-17-00116-f001}

![Three-dimensional (3D) response surface plots. (**a**) Hydrolysis degree (%) as a function of temperature (°C) × time (h); (**b**) ABTS^+•^ scavenging activity (%) as a function of temperature (°C) × time (h); (**c**) ABTS^+•^ scavenging activity (%) as a function of temperature (°C) × pH; (**d**) ABTS^+•^ scavenging activity (%) as a function of time (h) × pH.](marinedrugs-17-00116-g002){#marinedrugs-17-00116-f002}

![The effect of fractions with different MW from optimized hydrolysates on the ABTS^+•^ scavenging activity.](marinedrugs-17-00116-g003){#marinedrugs-17-00116-f003}

![Molecular docking model of the interactions between hLF1-11(GRRRRSVQWCA) and MPO, as well as between peptide no. 39 (DTETGVPT) with the active sites of MPO (Protein Data Bank (PDB) ID: 3F9P). The structure of hLF1-11 and peptide no. 39 are shown in green and blue stick representations, respectively, in the docking model shown on the left. The amino acid residues around the MPO active site that are involved in the interactions are labelled in magenta color. The interactions between peptides (hLF1-11 or peptide no. 39) and MPO active site are labelled in different colors for better visualization (charge interactions in orange color, conventional hydrogen bond in emerald green color, carbon hydrogen bond in light green color, pi sulfur interaction in light orange color, and alkyl interaction in light pink color).](marinedrugs-17-00116-g004){#marinedrugs-17-00116-f004}

![The docking pocket of human MPO (PDB ID: 3F9P).](marinedrugs-17-00116-g005){#marinedrugs-17-00116-f005}
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###### 

The experiment data for the hydrolysis degree and ABTS^+•^ scavenging activity of false abalone hydrolysates produced by trypsin using face-centered central composite design (F-CCCD).

  Run   Independent Variables   Responses               
  ----- ----------------------- ----------- --- ------- -------
  1     50                      4           7   12.44   77.56
  2     50                      4           7   12.81   77.49
  3     40                      5           7   6.11    65.99
  4     50                      5           8   10.09   77.34
  5     50                      3           8   9.22    74.53
  6     50                      4           7   12.23   77.28
  7     60                      3           7   6.24    69.25
  8     50                      3           6   3.33    66.37
  9     40                      4           6   4.03    62.15
  10    60                      5           7   5.37    72.39
  11    60                      4           8   10.16   75.23
  12    50                      5           6   4.25    66.57
  13    50                      4           7   12.35   77.85
  14    60                      4           6   5.06    64.25
  15    50                      4           7   12.35   77.26
  16    40                      3           7   3.88    65.14
  17    40                      4           8   8.67    69.25
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###### 

Statistical summary of the surface response analysis.

  Source        Response 1   Response 2                                 
  ------------- ------------ ------------ ---------- -------- --------- ----------
  Model         22.13        189.74       \<0.0001   56.43    334.76    \<0.0001
  A             2.14         18.37        0.0036     43.20    256.27    \<0.0001
  B             1.24         10.63        0.0138     6.13     36.34     0.0005
  C             57.62        493.99       \<0.0001   171.22   1015.74   \<0.0001
  AB            2.40         20.60        0.0027     1.31     7.78      0.0270
  AC            0.0529       0.4535       0.5223     3.76     22.33     0.0021
  BC            0.0006       0.0054       0.9437     1.70     10.10     0.0155
  A^2^          48.37        414.66       \<0.0001   171.87   1019.61   \<0.0001
  B^2^          55.99        480.06       \<0.0001   35.57    211.01    \<0.0001
  C^2^          17.99        154.19       \<0.0001   48.07    285.20    \<0.0001
  Residual      0.1166                               0.1686             
  Lack of fit   0.2065       4.19         0.1000     0.3162   5.46      0.0673
  Pure error    0.0493                               0.0579             

A is hydrolysis temperature, B is hydrolysis time, and C is hydrolysis pH. Response 1: *R*^2^ = 0.9959, Adj *R*^2^ = 0.9907, Pred *R*^2^ = 0.9489, Adeq Precision = 33.6087. Response 2: *R*^2^ = 0.9977, Adj *R*^2^ = 0.9947, Pred *R*^2^ = 0.9695, Adeq Precision = 50.0111.
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###### 

The energy and the amino acid residues involved in the interactions between peptides and myeloperoxidase (MPO) from the molecular docking study.

  Peptide no.   Peptide Sequence             Consensus Score   −CDOCKER Interaction Energy   Interactions with A Chain of MPO           Interactions with B Chain of MPO                           Interactions with C Chain of MPO                                                         Interactions with D Chain of MPO
  ------------- ---------------------------- ----------------- ----------------------------- ------------------------------------------ ---------------------------------------------------------- ---------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------
  hLF1-11       GRRRRSVQWCA                  \-                120.282                       ARG31, LEU33, PRO34                        VAL30, ARG31, TRP32                                        THR159, ASN162, ARG323, LYS505                                                           ALA152, CYS153, ILE160, ASN162, PHE439, LYS505
  39            DTETGVPT                     3                 121.516                       AGR31, TRP32                               ALA28, PHE29. VAL30, ARG31, TRP32                          ILE160, ARG323, LYS505                                                                   ALA152, CYS153, THR159, ILE160, ARG323, LYS505
  1             NDNIQR                       2                 96.9148                       ARG31, PRO34                               ARG31, TRP32, ALA35                                        ILE160, LYS505                                                                           ILE160, ASN162, ARG323, LYS505
  2             IELLLL                       2                 112.572                       ARG31, TRP32, PRO34                        ALA28, ARG31, PRO34, ALA35                                 ILE160, ASN162, PHE439                                                                   ALA152, CYS153, THR159, ILE160, ASN162, ARG323
  4             LADEIR                       2                 101.61                        ARG31, TRP32, PRO34                        VAL30, ARG31, TRP32                                        ILE160, ASN162, LYS505                                                                   ALA152, CYS153, ARG323
  5             LLKDQL                       2                 106.002                       ALA28, VAL30, ARG31, PRO34                 ALA28, TRP32                                               ILE160, ARG323, LYS505                                                                   ARG323, LYS505
  6             LEILNT                       2                 95.5421                       VAL30, ARG31                               ALA28, ARG31                                               ALA152, CYS153, ILE160, ASN162, ARG323, LYS505                                           THR159, ILE160, ASN162, ARG323
  8             QDPLNR                       2                 105.976                       PHE29, ARG31, TRP32, PRO34, ALA35          TRP32                                                      ILE160, ASN162                                                                           ASP321, ARG323, LYS505
  9             QVQNVR                       2                 94.6778                       ARG31, PRO34                               ARG31, TRP32, PRO34                                        ILE160, ASN162, ARG323                                                                   ILE160, ASN162, SER319, ARG323, LYS505
  10            GTELFR                       2                 97.3112                       ARG31, TRP32, PRO34                        ARG31, TRP32, ALA35                                        ASN162, ARG323, LYS505                                                                   ILE160, ASN162, ARG323, LYS505
  12            ISAAELR                      2                 99.0441                       ARG31, TRP32, ALA35                        ARG31                                                      ILE160, ARG323, LYS505                                                                   ILE160, ASN162, ARG323
  13            FPSIVGR                      2                 89.5673                       VAL30, ARG31                               ALA28, PHE29, VAL30, ARG31, PRO34, ALA35                   ILE160, ASN162, SER319, ARG323, LYS505                                                   ALA152, CYS153, ILE160
  14            LTGMAFR                      2                 90.0454                       ARG31, LEU33                               ARG31, TRP32, PRO34                                        ILE160, ARG323                                                                           ILE160, ASN162, ARG323, LYS505
  16            FAPQLLT                      2                 105.345                       ALA28, ARG31                               ALA28, PHE29, VAL30, ARG31, PRO34                          ILE160, ARG323                                                                           ILE160, ASN162, ARG323
  20            LEVNLMT                      2                 106.656                       PHE29, ARG31, TRP32, PRO34                 ALA28, ARG31, TRP32, LEU33                                 ILE160, ASN162, ARG323, LYS505                                                           ALA152, ILE160, ASN162, ARG323
  22            HLQLAIR                      2                 98.3054                       ALA28, ARG31, TRP32                        ARG31, TRP32                                               THR159, ILE160, ARG323                                                                   SER156, THR159, ILE160, ASP321, ARG323
  23            IAKEGFA                      2                 92.2588                       PHE29, ARG31, LEU33, PRO34                 ARG31, TRP32                                               THR159, ARG323, LYS505                                                                   ILE160, ASN162
  24            NLNPTTK                      2                 95.8118                       ARG31, TRP32, PRO34                        PHE29, ARG31, ALA35                                        CYS153, ARG323                                                                           ILE160, ASN162, ARG323
  25            VSHYSTK                      2                 90.9066                       ARG31                                      ALA28, ARG31, TRP32, ALA35                                 ILE160, ASN162, ARG323                                                                   ALA152, IEL160, ARG323
  28            GLLLHWS                      2                 99.7525                       ALA28, VAL30, ARG31, TRP32                 ALA28, PHE29, ARG31, TRP32, PRO34                          ALA152, CYS153, ILE160, ARG323, LYS505                                                   ILE160, ASN162, ARG323, LYS505
  29            LQLISAG                      2                 89.9116                       ALA28, ARG31, TRP32                        VAL30, ARG31                                               CYS153, ILE160, ARG161, ASN162, ASP321, ARG323, LYS505                                   ILE160, ASN162
  30            QCELNFK                      2                 103.547                       ARG31, PRO34                               \-                                                         ILE160, ASN162, ARG323, LYS505                                                           ALA152, CYS153, ASN162, ARG323
  31            GIHETTY                      2                 120.866                       VAL30, ARG31, PRO34                        ALA28, ARG31, TRP32, PRO34                                 THR159, ILE160, ASN162, ARG323                                                           ALA152, ILE160, ARG323
  45            VASFSTHK                     2                 97.4559                       ALA28, ARG31                               ALA28, VAL30, ARG31, TRP32                                 ILE160                                                                                   ALA152, SER319, ARG323, LYS505
  46            AVAGLGIL                     2                 94.3888                       ARG31, TRP32                               PHE29, ARG31, TRP32                                        ALA152, CYS153, ILE160, ASN162, ARG323, LYS505                                           CYS153, ILE160, ASN162, ARG323
  48            VGDEAQSK                     2                 114.397                       ARG31                                      ALA28, TRP32                                               YHR159, ILE160, ARG323                                                                   THR159, ILE160, ASN162, ARG323, LYS505
  49            SSSVVAAL                     2                 95.2041                       ARG31                                      ARG31, TRP32                                               ASN162, ARG323, LYS505                                                                   ALA152, CYS153, ASN162, ARG323
  50            FAGDDAPR                     2                 113.395                       ARG31, TRP32, PRO34                        PHE29, VAL30, ARG31, TRP32, PRO34                          ILE160, ASN162, ARG323                                                                   THR159, ILE160, ASN162, ARG323
  55            KTKDDMHL                     2                 111.666                       ARG31, TRP32, PRO34, ALA35                 ARG31, TRP32, PRO34                                        ILE160, ARG323, LYS505                                                                   CYS153, THR159, ILE160, ARG323
  58            VIPELNGK                     2                 108.917                       ALA28, ARG31                               ALA28, ARG31, ALA35                                        ARG323, LYS505                                                                           ILE160, ASN163, ARG323
  62            GFAGDDAPR                    2                 128.195                       ALA28, ARG31, TRP32, ALA35                 ALA28, ARG31, TRP32                                        ILE160, SER319, ARG323, LYS505                                                           ILE160, ASN162, ARG323
  64            VATVGPISV                    2                 96.6785                       ALA28, ARG31, PRO34                        ALA28, VAL30, ARG31, TRP32, PRO34                          THR159, ILE160, ARG323                                                                   ILE160, ASN162, ARG323, LYS505
  68            SSSVALHKH                    2                 78.6093                       ARG31, TRP32, PRO34                        ARG31, TRP32                                               PRO151, CYS153, THR159, ILE160, ARG161, ASN162, ARG323, LYS505                           THR159, ILE160, ARG323
  71            GGKNLDELE                    2                 145.154                       ARG31, PRO34                               ALA28, PHE29, ARG31, TRP32                                 ILE160, ARG323                                                                           CYS153, SER156, THR159, ILE160, ASN162, ASP321, ARG323, LYS505
  111           VGSSFVGGFG                   2                 103.741                       VAL30, ARG31, TRP32                        ALA28, ARG31                                               ILE160, ASN162, LYS505                                                                   PRO151, CYS153, SER156, THR159, ILE160, ARG161, ASN162, ARG323
  112           DVNSLKSALA                   2                 103.755                       ARG31, TRP32                               VAL30, ARG31, TRP32                                        CYS153, ILE160, ARG323, LYS505                                                           ALA152, CYS153, ILE160, ARG161, ASN162
  118           IGGIGTVPVGR                  2                 106.314                       ARG31, PRO34, SER42                        VAL30, ARG31, TRP32, PRO34                                 PRO151, ALA152, CYS153, SER156, ILE160, ASN162, ASN317, SER319                           ARG323, ARG438, PHE439
  125           AGLFVSSFFSV                  2                 116.238                       ALA28, ARG31, TRP32                        ALA28, VAL30, ARG31, PHE41                                 CYS153, LYS308, ASP321, ARG323, PHE439, LYS505                                           CYS153, SER156, THR159, ILE160, ARG323
  148           LTASGPSIGARP                 2                 122.053                       ARG31                                      ALA28, TRP32, ASP39                                        ARG323, LYS505, PHE439                                                                   PRO123, ALA152, CYS153, GLY155, SER156, THR159, ILE160, ARG161, ASN162
  182           ILVGAAVCFFCLILA              2                 116.4                         ALA28, PRO103                              ARG31, TRP32                                               PRO151, CYS153, PRO154, GLY155, SER156, THR159, ILE160, ARG161, ASN162, ARG323           ILE160, ASN162, LYS308, ASP321, ARG323, PHE439, LYS505
  183           STAGDTHLGGEDFDNR             2                 140.863                       ALA28, TRP32                               ARG31, PRG41, SER42, LEU43                                 LYS308, ASP321, ARG323, PHE439, CYS440, CYS497, CYS505, LYS505                           PRO151, CYS153, GLY155, THR159, ILE160, ARG161, ASN162, ARG323
  7             NWDLVG                       1                 99.433                        PHE29, VAL30, ARG31                        ALA28, PHE29, VAL30, ARG31, TRP32                          ARG323                                                                                   ARG323
  11            LLVKLL                       1                 86.1708                       ALA28, VAL30, ARG31, TRP32, PRO34          PHE29, VAL30, ARG31, PRO34                                 ALA152, CYS153, ASN162, ARG323, LYS505                                                   ILE160, ASN162
  15            FPGIADR                      1                 88.1065                       VAL30, ARG31                               PHE29, VAL30, ARG31, TRP32,                                ASN162, ARG323                                                                           ILE160, SER319, ARG323
  17            IIAPPER                      1                 96.3472                       VAL30, ARG31, TRP32, PRO34                 ALA28, ARG31, TRP32                                        ALA152, CYS153, IEL160, ASN162, ARG323, LYS505                                           ILE160, ARG323, LYS505
  21            LIILELL                      1                 98.6814                       ALA28, ARG31, TRP32, LEU33, PRO34          ALA28, VAL30, ARG31, PRO34                                 ILE160, ARG323, LYS505                                                                   ALA152, CYS153, ILE160, ASN162
  26            NLLNIPK                      1                 86.0812                       VAL30, ARG31, PRO34                        ARG31, TRP32, PRO34                                        ILE160, ARG323                                                                           THR159, ILE160
  27            SFRENNT                      1                 102.146                       ARG31, PRO34                               PHE29, ARG31, TRP32                                        ILE160, ASN162, LYS505                                                                   ASN162, ASP321, ARG323, LYS505
  32            TEAPLNPK                     1                 101.636                       VAL30, ARG31, TRP32, PRO34                 ALA28, ARG31, PRO34                                        THR159, ILE160, ASN162, LYS505                                                           ILE160, ASN162, ARG323
  34            IILLLLV                      1                 89.3092                       ALA28, VAL30, ARG31, TRP32, PRO34, ALA35   VAL30, TRP32, PRO34                                        ILE160, ASN162, ARG323, LYS505                                                           ILE160
  35            SFTTTAER                     1                 111.511                       ARG31, TRP32                               PHE29, VAL30, ARG31, TRP32                                 THR159, LYS505                                                                           CYS153, SER156, THR159, ASN162
  37            TLEEEKLQ                     1                 127.638                       ARG31, TRP32, PRO34                        ALA28, TRP32, LEU33, PRO34                                 ILE160, ASN162, ARG323, LYS505                                                           ALA152, CYS153, THR159, ILE160, ARG323
  40            FLNNNALT                     1                 88.3879                       ARG31, TRP32                               ARG31                                                      THR159, ARG323                                                                           ILE160, ASN162, SER319, VAL320, ARG323
  41            LEVLGVPA                     1                 96.8835                       PHE29, VAL30, ARG31, TRP32, LEU33, PRO34   ALA28, VAL30, ARG31, PRO34                                 CYS153, THR159, ILE160, ASN162, ARG323, LYS505                                           ILE160
  42            KLDEKIVQ                     1                 102.044                       VAL30, ARG31, LEU33, PRO34                 ALA28, ARG31, PRO34, SER42                                 ARG323                                                                                   ALA152, CYS153, ILE160, ARG161, ASN162, SER319, ARG323, LYS505
  44            TVPIYEGY                     1                 88.1488                       VAL30, TRP32, SER42                        ALA28, ARG31, TRP32                                        ALA152, CYS153, SER156, THR159, ILE160, ARG161, ASN162                                   ASN162
  52            SVKNTAGL                     1                 89.225                        ARG31, LEU33                               ALA28, ARG31                                               CYS153, ASN162, ARG323                                                                   ILE160, ARG323, LYS505
  53            ADINAADQ                     1                 121.529                       ARG31                                      ARG31, TRP32, LEU33, PRO34                                 ALA152, CYS153, ILE160, ASN162                                                           THR159, ILE160, ASN162, ARG323, LYS505
  54            KTWVKELQ                     1                 80.8878                       ALA28, ARG31, PRO34, SER42                 ARG31, TRP32,                                              CYS153, THR159, ILE160, ASN162                                                           ILE160, ARG323, LYS505
  57            EEQVAAIR                     1                 124.143                       ARG31, TRP32                               PHE29, ARG31, PRO34, ALA35                                 THR159, ILE160, ARG323, PHE439                                                           ALA152, CYS153, THR159, ILE160, SER319, ARG323, LYS505
  63            MGSTLIMLL                    1                 120.627                       VAL30, ARG31, TRP32, LEU33, PRO34          ALA28, VAL30, ARG31                                        ILE160, ASN162, PHE439, LYS505                                                           PRO151, CYS153, SER156, THR159, ILE160, ANS162
  70            LGKTVPDDV                    1                 88.3103                       ARG31, TRP32, LEU33, PRO34                 PHE29, ARG31, PRO34                                        ILE160, ASN162, ARG323, LYS505                                                           PRO151, ALA152, CYS153, ILE160, ARG161, ANS162, ARG323
  73            QVITIGNER                    1                 113.155                       ALA28, VAL30, ARG31, PRO34                 ALA28, VAL30, ARG31, LEU33, ALA35                          ARG323, LYS505                                                                           ALA152, PRO154, GLY155, SER156, THR159, ILE160, ANS162, SER319, ARG323, LYS505
  74            LSDLSPFPG                    1                 82.875                        TRP32                                      ALA28, PHE29, ARG31, TRP32, PRO34                          ALA152, CYS153, THR159, ILE160, ASN162, ARG323, LYS505                                   ALA152, CYS153, THR159, ILE160, ARG161, ANS162, PHE439
  78            VGYDALTDQ                    1                 133.602                       ALA28, VAL30, ARG31, TRP32                 ARG31, PRO34, ALA35                                        ALA152, CYS153, ARG323, LYS505                                                           PRO151, CYS153, SER156, THR159, ILE160, ARG161, ANS162, ARG323, LYS505
  81            IEAIDQVGS                    1                 124.082                       ARG31, LEU33                               VAL30, ARG31, SER42                                        CYS153, THR159, ASN162, ARG323, PHE439                                                   CYS153, GLY155, SER156, THR159, ILE160, ASN162, ARG323, LYS505
  82            MKNPKASVL                    1                 48.301                        ARG31, TRP32                               \-                                                         ILE160, LYS505                                                                           SER156, THR159, ILE160, ASN162, ARG323, PHE439
  84            LIIIIAAMT                    1                 80.6012                       VAL30, ARG31, TRP32                        ALA28, ARG31, PRO34, ALA35                                 ILE160, ASN162                                                                           CYS153, ILE160, ASN162
  90            AGFAGDDAPR                   1                 118.225                       ARG31, PRO34                               ALA28, VAL30, ARG31, PRO34                                 ARG323                                                                                   CYS153, SER156, THR159, ILE160, ASN162, ARG323
  91            DAVTYTEHAK                   1                 130.855                       VAL30, ARG31, PRO34                        ARG31, PHE41                                               ILE160, ARG323, LYS505                                                                   CYS153, PRO154, GLY155, SER156, THR159, ILE160, ARG161, ASN162, ARG323, PHE439
  94            VLMILPSVTG                   1                 80.7513                       VAL30, ARG31, PRO34, ALA35                 ALA28, ARG31, TRP32, LEU33, PRO34                          ILE160, ASN162, ARG323                                                                   PRO151, ALA152, CYS153, GLY155, THR159, ILE160, ARG161, ARG323, PHE439
  107           DSGLLTPESV                   1                 88.9027                       ALA28, ARG31, SER42                        ARG31, TRP32, PRO34                                        CYS153, GLY155, SER156, THR159, ILE160, ARG161, ASN162, ARG323, LYS505                   ILE160
  109           VEQEILETGI                   1                 95.3997                       ARG31, TRP32                               VAL30, ARG31, TRP32, PHE41                                 THR159, ASN162, ARG323, LYS505                                                           ALA152, PRO154, GLY155, SER156, THR159, ILE160, ARG161, ANS162, ARG323, LYS505
  113           SDDLDLGQVG                   1                 63.6376                       ARG31, PRO34                               VAL30, ARG31, TRP32, PRO34                                 ARG323, LYS505                                                                           ARG148, CYS153, GLY155, SER156, THR159, ILE160, ARG161, ANS162
  114           HQGVMVGMGQK                  1                 108.89                        ALA28, VAL30, ARG31, TPR32                 ARG31, ASP39, SER42                                        THR159, PHE439, LYS505                                                                   PRO151, ALA152, CYS153, THR159, ILE160, ARG161, ANS162
  122           LSAAGLEAGNV                  1                 104.596                       ARG31, TRP32                               ARG31, SER42                                               THR159, ARG323                                                                           ALA152, CYS153, PRO154, GLY155, SER156, THR159, ILE160, ANS162, SER319, ASP321, ARG323
  123           ATAASSSSLEK                  1                 107.999                       ARG31, TRP32, PRO34                        VAL30, ARG31, ASP39, SER42                                 ARG323, PHE439, LYS505                                                                   CYS153, GLY155, THR159, ILE160, ARG161, ASN162
  124           VVVYGGVAVNH                  1                 58.4842                       ARG31                                      ALA28, ARG31, PRO34, PHE41, SER42                          ASN162, ARG323, PHE439                                                                   ARG148, PRO151, ALA152, CYS153, SER156, THR159, ILE160, ANS162, ARG323
  130           KAGSERNVLIF                  1                 127.874                       ARG31, TRP32, PRO34, ALA35, ASP39, SER42   ARG31, PRO34                                               CYS153, PRO154, GLY155, SER156, SER156, THR159, ILE160, ARG161, ASN162, PHE439, LYS505   ILE160, ARG161, ARG323, LYS505
  137           IGLFGGAGVGK                  1                 104.383                       ALA28, ARG31, PRO34                        PHE29, ARG31, PRO34, PHE41                                 ARG323, PHE439, LYS505                                                                   PRO151, CYS153, SER156, THR159, ILE160, ARG323
  139           TLSIQNDQASQR                 1                 116.278                       ARG31, TRP32                               \-                                                         ILE160, ARG161, ASN162, ARG323, PHE439, CYS497, LYS505                                   ARG148, CYS153, ARG161, ASN162, SER156, THR159, ILE160, ARG323
  142           DSYVGDEAQSKR                 1                 91.8078                       PRO34                                      ARG31                                                      ARG323, PHE439                                                                           CYS153, GLY155, SER156, THR159, ILE160, ARG161, SER319, ARG323, ARG504
  152           YISHIELAFSSV                 1                 122.83                        ARG31, TRP32, PRO34                        ALA28, TRP32                                               ARG323, PHE439, LYS505                                                                   PRO151, CYS153, PRO154, GLY155, SER156, THR159, ILE160, ASN162
  154           EGGGIVESIGEG                 1                 150.197                       ARG31, TRP32, PRO34                        ARG31, TRP32, SER42                                        ALA152, ARG323, LYS505                                                                   ALA152, CYS153, SER156, ILE160, ARG161, ARG323, PHE439
  155           CRPGALESGPAL                 1                 91.9951                       ALA28, PRO34                               ARG31                                                      ALA152, CYS153, PRO154, GLY155, SER156, ILE160, ARG161, ASN162, ARG323                   ILE160, ARG323, PHE439, LYS505
  156           FNLWGLSCSSLL                 1                 88.0987                       VAL30, ARG31, TRP32, PRO34                 VAL30, ARG31, PRO34, SER42, LEU43                          ASN162                                                                                   PRO123, ARG148, PRO151, CYS153, GLY155, SER156, THR159, ILE160, ARG161, ASN162, ASP321, ARG323
  161           AKCGAYQGQVLIF                1                 114.346                       ARG31, TRP32                               TRP32                                                      ILE160, ASN162, LYS308, ARG323, PHE439                                                   CYS153, SER156, THR159, ILE160, ARG161, ASN162
  169           FTQAGSEVSALLGR               1                 130.617                       ARG31, PRO34                               VAL30, ARG31                                               \-                                                                                       CYS153, GLY155, SER156, ILE160, ARG161, ASN162, ARG323, PHE439
  170           TTGIVLDSGDGVTH               1                 95.5298                       ARG31, PRO34                               VAL30, ARG31, PRO34, SER42                                 ASN162, ARG323, ARG438, PHE439, GLY441                                                   PRO123, PRO151, CYS153, PRO154, GLY155, SER156, THR159, ILE160, ARG161, SER319, ARG323
  172           AHGGYSVFAGVGER               1                 106.868                       VAL30, ARG31                               PHE29, VAL30, ARG31, TRP32, SER42                          CYS153, ASN162, PHE439, LYS505                                                           ARG148, ALA152, CYS153, PRO154, GLY155, THR159, ARG161, ASN162, ARG323, LYS505
  177           ELPDGQVITIGNER               1                 113.61                        ARG31, TRP32, PRO34, ASP39, SER42          ALA28, ARG31, TRP32, LEU33, PRO34                          CYS153, GLY155, SER156, THR159, ILE160, ARG161, ASN162, SER319. ARG323, LYS505           THR159, ASP321, ARG323
  178           SAYLVLTITIAAMT               1                 111.103                       ARG31, TRP32, PRO34                        ALA28, ARG31, PHE41                                        CYS153, ILE160, ARG438, PHE439, LYS505                                                   ALA152, CYS153, GLY155, SER156, THR159, ILE160, ARG161, ASN162, ARG323
  180           WEDLANEIQEELNK               1                 107.719                       ARG31, TRP32                               VAL30, ARG31, TRP32, PRO34, PHE41                          THR159, ARG438, CYS440, GLY441, LYS505                                                   PRO123, ARG148, PRO151, ALA152, CYS 153, THR159, ILE160, ARG161, ASN162, ARG323, LYS505
  186           EQEGGLGNFMNFMKENG            1                 163.68                        TRP32, PRO34                               ALA28, PHE29, ARG31, LEU33, PRO34, PHE41, PRO101, PRO103   ILE160, ARG323, PHE439, CYS440                                                           PRO124, PRO151, CYS153, SER156, THR159, ILE160, ARG161, ASN162, SER319
  51            LILLIRAK                     0                 74.004                        ALA28, PHE29, ARG31, TRP32, PRO34          ALA28, ARG31, PRO34, SER42                                 ILE160, PHE439, LYS505                                                                   ALA152, CYS153, SER156, ILE160, ARG161, ANS162
  59            LARDKAAN                     0                 94.6022                       ARG31, TRP32                               PHE29, VAL30, ARG31, LEU33                                 THR159, ILE160, ASN162, ARG323, LYS505                                                   THR159
  67            VLFPLTTLQ                    0                 72.9901                       VAL30                                      ARG31, TRP32, SER42                                        CYS153, LYS505                                                                           PRO151, ALA152, CYS153, SER156, ARG161, ANS162, ARG323
  72            SMSFFGLIM                    0                 86.9571                       \-                                         ALA28, ARG31, TRP32, PRO34                                 ASN162, ARG323, PHE439                                                                   PRO151, ALA152, ILE160, ARG161, ASN162, ASP321, LYS505
  85            ISGLIYEETR                   0                 75.3523                       ARG31, TRP32, SER42                        ALA28, ARG31, LEU33, PRO34                                 CYS153, PRO154, GLY155, SER156, THR159, ILE160, ASN162, ARG323, LYS505                   CYS153, ARG323
  99            VVTSGNSLNG                   0                 93.2669                       VAL30, ARG31, TRP32                        PHE29, ARG31, TRP32                                        ILE160, ARG323, PHE439                                                                   ALA152, CYS153, ILE160, ANS162, LYS505
  117           VEIIANDQGNR                  0                 114.499                       ARG31, PRO34                               VAL30, ARG31, SER42                                        ASN162, ARG323, PHE439                                                                   ARG148, CYS153, GLY155, SER156, THR159, ILE160, ARG161, ASN162, ARG323
  121           PTKVGINGFGR                  0                 81.1789                       ALA28, PHE29, ARG31, TRP32                 ALA28, SER42                                               LYS505                                                                                   CYS153, GLY155, SER156, THR159, ILE160
  140           ELISNASDALDK                 0                 74.9956                       ARG31, TRP32, TRP47                        LEU33                                                      ARG148, PRO151, CYS153, PRO154, THR159, ILE160, ARG161, ASN162, ARG323, LYS505           ARG323
  162           LLTLATCVGDGPA                0                 72.2681                       VAL30, ARG31, TRP32, SER42                 ARG31                                                      CYS153, GLY155, SER156, THR159, ILE160, ARG161, ASN162                                   CYS153, LYS505
  164           RSLGDFACQLEHL                0                 75.728                        ARG31, SER42                               TRP32                                                      PRO151, CYS153, GLY155, SER156, THR159, ILE160, ARG161, LYS505                           THR159, LYS308, ARG323, PHE439, CYS440
  171           LISWYDNEYGYSNR               0                 137.019                       ALA28, ARG31, TRP32, PRO34                 PHE29, PHE41, SER42                                        THR159, ASN162                                                                           ALA152, CYS153, PRO154, SER156, THR159, ARG161, ASN162, VAL320, ASP321, ARG323
  191           LVQDVANNTNEEAGDGTTTATVLAR    0                 120.381                       VAL30, ARG31, TRP32, LEU33                 VAL30, TRP32, LEU43                                        THR159, ILE160, PHE439                                                                   CYS153, GLY155, SER156, ASN157, THR159, ILE160, ARG161, ASN317, SER319, ARG323, ARG504, LYS505
  192           AQTISYEVSMALVLLFPLFLGGSFSF   0                 185.828                       TRP32                                      ARG31, TRP32, PRO34, SER42                                 ASN162, ARG323, PHE439, GLY441, PRO443, LYS505                                           GLN122, PRO123, CYS153, PRO154, GLY155, SER156, THR159, ILE160, ARG161, ASN162, ARG323, LYS505

[^1]: These authors contributed equally to this work.
